Literature DB >> 12184527

Cystic fibrosis transmembrane conductance regulators (CFTR) in biliary epithelium of patients with hepatolithiasis.

Hong-Ja Kim1, Sung-Koo Lee, Myung-Hwan Kim, Jeoung-Min Son, Sang-Soo Lee, Ju-Sang Park, Dong-Wan Seo, Young-Il Min.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) has been considered to be involved in the regulatory pathway of biliary mucin secretion. We investigated expression of CFTR protein and mRNA in 24 livers with hepatolithiasis, in 6 with cholangiocarcinoma, and in 12 histologically normal livers. According to the histologic features of chronic proliferative cholangitis, hepatolithiasis was subdivided into inflammatory cell infiltration predominant (N = 14) and fibrosis predominant (N = 10). The mean signal density of CFTR in overall hepatolithiasis and in histologically normal livers was 1.23 +/- 0.15 and 1.01 +/- 0.13, respectively (P > 0.05). The CFTR protein (1.60 +/- 0.18) and mRNA (1.09 +/- 0.15) in inflammatory cell infiltration predominant patients were significantly higher (CFTR protein, 1.01 +/- 0.13; mRNA, 0.75 +/- 0.11) than in control subjects (P < 0.05), whereas those in fibrosis-predominant patients (CFTR protein, 0.72 +/- 0.15; mRNA, 0.55 +/- 0.13) were less than in control subjects (P < 0.05). CFTR protein (1.27 +/- 0.17) in patients with cholangiocarcinoma was not different from that of control subjects (1.01 +/- 0.13). CFTR expression in hepatolithiasis patients was rather heterogeneous but was closely related to the histology of bile ducts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184527     DOI: 10.1023/a:1016488327019

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

Review 1.  Oriental cholangiohepatitis: pathologic, clinical, and radiologic features.

Authors:  J H Lim
Journal:  AJR Am J Roentgenol       Date:  1991-07       Impact factor: 3.959

2.  Biliary strictures as a cause of primary intrahepatic bile duct stones.

Authors:  Y Matsumoto; H Fujii; M Yoshioka; T Sekikawa; T Wada; M Yamamoto; H Eguchi; K Sugahara
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 4.  Primary sclerosing cholangitis.

Authors:  Y M Lee; M M Kaplan
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

Review 5.  Hepatolithiasis: present status.

Authors:  F Nakayama; A Koga
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction.

Authors:  M Sasaki; Y Nakanuma; Y S Kim
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

8.  Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones.

Authors:  F M Cetta
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

Review 9.  Biliary stone disease in adults with cystic fibrosis.

Authors:  W J Scott; G E Block
Journal:  Surgery       Date:  1989-05       Impact factor: 3.982

Review 10.  Liver and biliary problems in cystic fibrosis.

Authors:  C Colombo; P M Battezzati; M Strazzabosco; M Podda
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

View more
  1 in total

1.  Multidisciplinary Treatment of Cystic Fibrosis-Related Recurrent Pyogenic Cholangitis (CF-RPC).

Authors:  James Buxbaum; Nancy Nguyen; Sujit Kulkarni; Suzanne Palmer; Adupa Rao; Robert Selby
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.